CANSF CanSino Biologics Inc. Loading...

Loading chart...
Top Calls
Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
06:07
Aug 28
Xuefeng Yu Chairman and CEO, CanSino Biologics Bloomberg Markets
Vaccine sales and mRNA pipeline drive growth.
CanSino Biologics is transitioning to profitability with strong revenue growth driven by its meningococcal and pneumococcal conjugate vaccines, significant international market expansion, and a promising mRNA pipeline for cancer therapeutics.
CANSF 1ST
HIGH

About CANSF Analyst Coverage

Buzzberg tracks CANSF (CanSino Biologics Inc.) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade idea tracked. Past 7 days: 1 bullish. Latest voices: Xuefeng Yu.